Treat the Symptom, Not the Cause? Pitolisant for Sleepiness in Obstructive Sleep Apnea.
作者信息
Trotti Lynn Marie
机构信息
Department of Neurology and Emory Sleep CenterEmory University School of MedicineAtlanta, Georgia.
出版信息
Am J Respir Crit Care Med. 2020 May 1;201(9):1033-1035. doi: 10.1164/rccm.202001-0104ED.
Abstract
摘要
相似文献
1
Treat the Symptom, Not the Cause? Pitolisant for Sleepiness in Obstructive Sleep Apnea.
Am J Respir Crit Care Med. 2020 May 1;201(9):1033-1035. doi: 10.1164/rccm.202001-0104ED.
2
Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure.
J Sleep Res. 2013 Aug;22(4):389-97. doi: 10.1111/jsr.12039. Epub 2013 Feb 15.
3
[Sleepiness, continuous positive airway pressure and the obstructive sleep apnea hypopnea syndrome].
Rev Mal Respir. 2018 Feb;35(2):116-133. doi: 10.1016/j.rmr.2017.04.005. Epub 2018 Feb 15.
4
Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy.
Expert Opin Emerg Drugs. 2015;20(4):571-82. doi: 10.1517/14728214.2015.1115480. Epub 2015 Nov 24.
5
Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis.
Lancet Respir Med. 2015 Nov;3(11):869-78. doi: 10.1016/S2213-2600(15)00416-6. Epub 2015 Oct 20.
6
Continuous positive airway pressure probably results in fewer apnea-hypopnea episodes per hour but not in less sleepiness compared with mandibular advance devices in patients with obstructive sleep apnea.
J Am Dent Assoc. 2018 Apr;149(4):e67. doi: 10.1016/j.adaj.2017.12.004. Epub 2018 Jan 17.
7
Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.
Sleep Med Clin. 2016 Sep;11(3):353-63. doi: 10.1016/j.jsmc.2016.05.005. Epub 2016 Jun 16.
8
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort.
J Sleep Res. 2018 Dec;27(6):e12705. doi: 10.1111/jsr.12705. Epub 2018 May 24.
9
Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea.
J Sleep Res. 2019 Oct;28(5):e12761. doi: 10.1111/jsr.12761. Epub 2018 Sep 20.
10
Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
Sleep. 2005 Apr;28(4):464-71. doi: 10.1093/sleep/28.4.464.
引用本文的文献
1
Histamine, Neuroinflammation and Neurodevelopment: A Review.
Front Neurosci. 2021 Jul 14;15:680214. doi: 10.3389/fnins.2021.680214. eCollection 2021.
2
Pitolisant and Other Histamine-3 Receptor Antagonists-An Update on Therapeutic Potentials and Clinical Prospects.
Medicines (Basel). 2020 Sep 1;7(9):55. doi: 10.3390/medicines7090055.
本文引用的文献
1
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
Am J Respir Crit Care Med. 2020 May 1;201(9):1135-1145. doi: 10.1164/rccm.201907-1284OC.
2
Cognitive Improvements in Children with Prader-Willi Syndrome Following Pitolisant Treatment-Patient Reports.
J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):166-171. doi: 10.5863/1551-6776-24.2.166.
3
Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment.
J Clin Sleep Med. 2019 Feb 15;15(2):301-334. doi: 10.5664/jcsm.7638.
4
Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline.
J Clin Sleep Med. 2019 Feb 15;15(2):335-343. doi: 10.5664/jcsm.7640.
5
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1421-1431. doi: 10.1164/rccm.201806-1100OC.
6
The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice Guideline.
Am J Respir Crit Care Med. 2018 Sep 15;198(6):e70-e87. doi: 10.1164/rccm.201807-1326ST.
7
Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials.
Thorax. 2019 Apr;74(4):390-396. doi: 10.1136/thoraxjnl-2018-211959. Epub 2018 Aug 12.
8
The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea.
Am J Respir Crit Care Med. 2018 Apr 1;197(7):961-963. doi: 10.1164/rccm.201704-0672LE.
9
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
Lancet Neurol. 2017 Mar;16(3):200-207. doi: 10.1016/S1474-4422(16)30333-7. Epub 2017 Jan 25.
10
Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
Clin Ther. 2016 Apr;38(4):874-88. doi: 10.1016/j.clinthera.2016.02.004. Epub 2016 Feb 28.
Zotero 插件